What this shows
Market trades first
This view focuses on purchases and sales with reported trade value. Lower-signal rows are moved out of the first screen, not hidden.
Ticker page
RAPP Insider Trading Activity
Track Rapport Therapeutics, Inc. (RAPP) insider transactions, SEC Form 4 filings, insider buys, insider sales, filing dates, trade values, and source links. Recent summary: 10 trades, 0 buys, and 0 sales. Learn more
Feed status Last SEC check:Loading Last Filing: Loading
View RAPP
Access Free feed
Quick read What does this view show?
Why it matters
Use it as the default scan
Start here when you want the newest activity that most retail investors expect from an insider trading feed.
How to read it
Open the full ledger when needed
Use All Form 4 Filings when you want grants, exercises, gifts, conversions, and every normalized row.
Stacked feeds
Key insider views at a glance
Filings
RAPP Form 4 filing history
Status Loading
Latest visible filing loading.
Public Form 4 filings, normalized for cleaner scanning. What do these codes mean?
| Ticker | Type & Role | Value | |
|---|---|---|---|
Grant Director | $0 | ||
Sell 10% Owner | $17.2M | ||
Sell 10% Owner | $17.2M | ||
Sell 10% Owner | $17.2M | ||
Sell 10% Owner | $17.2M | ||
Sell 10% Owner | $17.2M | ||
Sell 10% Owner | $17.2M | ||
Sell Officer | $808.8K | ||
Sell Officer | $357.8K | ||
Sell Officer | $320.5K | ||
Cluster detail
Cluster members
Ticker context
Ticker summary
Recent insider activity for this company.
Insider detail
Insider activity
Recent transactions grouped by reporting owner.
Filters
Filters
Latest news
RAPP headlines
- Is Rapport Therapeutics, Inc. (RAPP) A Good Stock To Buy Now? · Jun 16, 2026
- Is Rapport Therapeutics (RAPP) Using RAP-219 To Redefine Its Broader Neuroscience Investment Narrative? · Jun 8, 2026
- BTIG Raises its Price Target on Rapport Therapeutics (RAPP) · Jun 5, 2026
- Rapport Therapeutics, Inc. (RAPP) Reports Q1 Loss · May 7, 2026
- Rapport Therapeutics Insiders Added US$1.61m Of Stock To Their Holdings · Apr 30, 2026
Plain-English summary
RAPP insider activity summary
Rapport Therapeutics, Inc. (RAPP) insider activity over the recent reporting window shows no qualifying Form 4 activity in the recent window. Market data shows a current price of $36.87 and a market capitalization of $1.84B. Blue Collar Picks normalizes public SEC Form 4 filings into a research-friendly view organized by ticker, insider role, transaction type, filing date, and reported value. RAPP pages are designed as a research starting point, not investment advice. Verify the original SEC filing, read the transaction code, compare the trade against the insider's role and history, and consider whether the activity is an open-market purchase, a sale, a grant, an option exercise, or another lower-signal filing type before drawing conclusions.
Company snapshot
Rapport Therapeutics, Inc. at a glance
Context
Earnings & analyst view
Earnings
Aug 5, 2026
Analyst View
$57.10 +48.70% upside
Target range $40.00–$80.00.
Cluster activity
Recent insider clusters for RAPP
Filings where three or more insiders bought RAPP shares within a short window. Each link opens the cluster page with the full member breakdown.
Ownership context
Top institutional holders
| Holder | Shares | % Held | Value | Reported |
|---|---|---|---|---|
| FMR, LLC | 7,168,939 | 0.15% | $275.3M | Mar 31, 2026 |
| Trv Gp V, LLC | 7,135,233 | 0.15% | $274.0M | Mar 31, 2026 |
| Arch Venture Management, Llc | 3,728,738 | 0.08% | $143.2M | Mar 31, 2026 |
| Capital International Investors | 3,097,973 | 0.06% | $119.0M | Mar 31, 2026 |
| Cormorant Asset Management, LP | 2,957,521 | 0.06% | $113.6M | Mar 31, 2026 |
Primary source
Verify with the original SEC filings
Blue Collar Picks normalizes public Form 4 records but the SEC filing is the source of record. Use the original filing before making any investment decision.
Open RAPP Form 4 filings on SEC EDGAR → See insider trading stocks ranked by activity → Read the Blue Collar Picks methodology → Read the investment disclaimer →
Weekly recap
Get the easier version in your inbox.
Start with the free weekly recap. Upgrade later if you want the paid daily brief.
Free weekly recap. No login required. Unsubscribe any time.
Method Public Form 4 filings, normalized for cleaner scanning. Filtered rows stay available in All Form 4 Filings and ticker history. Which view should I use? →
Paid research tools
CSV exports are becoming a paid feature.
Join the waitlist for founding-member access to CSV exports, saved screens, and premium download tools when they open.